Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease
Allergy · 2026-11 · 81 (11) · 4088-4091
DOI: 10.1111/all.70458 ↗At a glance
Leserbrief in Allergy, published online on 2026-07-23. Written by Masaki Orihara and 22 co-authors. Institution: Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Mayo Clinic.
Abstract (original language)
The data that support the findings of this study are available from the corresponding author upon reasonable request. Figure S1: Study flow diagram. N-ERD, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; NT-CRSwNP, NSAID-tolerant chronic rhinosinusitis with nasal polyps. Table S1: Baseline demographic characteristics of the discovery and validation cohorts. Table S2: Diagnostic performance of urinary LTE4 for identification of N-ERD in the validation cohort at two cutoff values. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Subjects
Author keywords
Authors and institutions
- Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic, Jacksonville, Florida, USA.
- Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
ORCID profiles: Masaki Orihara, Anthony Maus, Patrick M Vanderboom, Kayla Moehnke, Alessandra Tomasello, Katherine N Cahill, Chien-Chang Chen, Maria Vorobeva, Aleksandr iAkushev, Sergio E Chiarella, Kimberly G Blumenthal, Janalee K Stokken, Jacob G Eide, Rijul S Kshirsagar, Nadeem Akbar, Patrick Colley, Golda Hudes, Erin K O'Brien, Hirohito Kita, Rohit Divekar, Hamid R Tizhoosh, Diane E Grill, Elina Jerschow
Funding
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Mayo Clinic
Cite
APA
Orihara, M., Maus, A., Vanderboom, P. M., Moehnke, K., Tomasello, A., Cahill, K. N., Chen, C. C., Vorobeva, M., iAkushev, A., Chiarella, S. E., Blumenthal, K. G., Stokken, J. K., Eide, J. G., Kshirsagar, R. S., Akbar, N., Colley, P., Hudes, G., O'Brien, E. K., Kita, H., …, & Jerschow, E. (2026). Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease. Allergy, 81(11), 4088-4091. https://doi.org/10.1111/all.70458
Vancouver
Orihara M, Maus A, Vanderboom PM, Moehnke K, Tomasello A, Cahill KN, et al. Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease. Allergy. 2026;81(11):4088-4091. doi:10.1111/all.70458
BibTeX
@article{Orihara2026,
author = {Orihara, Masaki and Maus, Anthony and Vanderboom, Patrick M and Moehnke, Kayla and Tomasello, Alessandra and Cahill, Katherine N and Chen, Chien-Chang and Vorobeva, Maria and iAkushev, Aleksandr and Chiarella, Sergio E and Blumenthal, Kimberly G and Stokken, Janalee K and Eide, Jacob G and Kshirsagar, Rijul S and Akbar, Nadeem and Colley, Patrick and Hudes, Golda and O'Brien, Erin K and Kita, Hirohito and Divekar, Rohit and Tizhoosh, Hamid R and Grill, Diane E and Jerschow, Elina},
title = {Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease},
journal = {Allergy},
year = {2026},
volume = {81},
number = {11},
pages = {4088--4091},
doi = {10.1111/all.70458}
}
EUVIMED